Evidence map›Paper›PMID 41254604›Full record

ArticleBMC medical imaging2025

MRI cytometry imaging for cervical cancer differential diagnosis: a preliminary study.

Zhi-Lin Yuan, Di-Wei Shi, Hui Guan, Fan Liu, Zong-Shu Wang, Shang-Ying Yang, Xin Gao, Thorsten Feiweier, Jin-Xia Zhu, Zheng-Yu Jin and 5 more

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhi-Lin Yuan *Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Di-Wei Shi *Research Institute of Tsinghua University in Shenzhen, No. 19 Gaoxin South 7th Avenue, Nanshan District, Shenzhen, Guangdong, China.
Hui Guan *Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Fan LiuCenter for Biomedical Imaging Research, School of Biomedical Engineering, Tsinghua University, Beijing, PR China.
Zong-Shu WangTanwei College, Tsinghua University, Beijing, PR China.
Shang-Ying YangDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Xin GaoDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Thorsten FeiweierResearch & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany.
Jin-Xia ZhuMR Research Collaboration, Siemens Healthineers, Beijing, China.
Zheng-Yu JinDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Jun-Zhong XuInstitute of lmaging Science, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Yuan LiDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, PR China. liyuan10833@pumch.cn.
Hua-Dan XueDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China. bjdanna95@hotmail.com.
Yong-Lan HeDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China. ylhe_526@163.com.
Hua GuoCenter for Biomedical Imaging Research, School of Biomedical Engineering, Tsinghua University, Beijing, PR China.

Funding

National High Level Hospital Clinical Research Funding 2025-PUMCH-C-029National Science Foundation of China-Youth Fund-62401329 2024-NSFC-62401329the CAMS Innovation Fund for Medical Sciences 2023-I2M-C&T-B-020
6 · The paper itself

Abstract

backgroundPrecise noninvasive detection and differentiation of pathological subtypes in cervical cancer remains challenging. Diffusion MRI (dMRI)-based cytometry, an imaging technique quantifying tumor microenvironments, shows diagnostic potential but requires clinical validation.

methods74 patients with cervical cancer and 44 healthy volunteers underwent diffusion-weighted imaging using oscillating gradient spin-echo (OGSE) and pulsed gradient spin-echo (PGSE) sequences at 3T. Three radiologists independently scored image quality on a 5-point scale. Time-dependent apparent diffusion coefficients (ADCs) as well as information from 'imaging microstructural parameters using limited spectrally edited diffusion' (IMPULSED) alone or incorporating transcytolemmal water exchange (JOINT) were used to distinguish cancerous from normal tissues and identify tumor subtypes. The microstructural parameters included intracellular volume fraction ([Formula: see text]), cell diameter ([Formula: see text]), extracellular diffusivity ([Formula: see text]), and water exchange rate constant ([Formula: see text]). Receiver operating characteristic (ROC) curves were used to assess the effectiveness.

resultsKendall's W statistics showed strong inter-reader reliability for assessing OGSE and PGSE images (W = 0.819, P < 0.0001). Microstructural parameters can effectively distinguish cervical cancer from normal tissues, with higher [Formula: see text] (P < 0.01), lower [Formula: see text] (P < 0.0001), and higher [Formula: see text] (P < 0.0001) values for tumors. Additionally, squamous carcinomas were characterized by lower [Formula: see text] and [Formula: see text] values (P < 0.01 and P < 0.05). The area under ROC curve of the combined regression model can reach up to 0.967 and 0.853 for diagnosing cervical cancer and differentiating the subtypes, respectively.

conclusionsMRI cytometry-derived microstructural parameters can reliably detect cervical cancer and further differentiate its pathological subtypes. This improves the accuracy of noninvasive preoperative assessment and shows considerable clinical potential.

Indexed as

Diffusion Magnetic Resonance ImagingUterine Cervical NeoplasmsAdultAgedCase-Control StudiesDiagnosis, DifferentialFemaleHumansMiddle AgedReproducibility of ResultsROC CurveCervical cancerDiagnosisDiffusion magnetic resonance imagingMicrostructural imagingMRI cytometry

Identifiers

PMID41254604
PMCPMC12624987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.